3rd Quarter - Report

THORN RUN PARTNERS for HARMONY BIOSCIENCES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to the orphan drug tax credit. Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.

LobbyistCovered position, as disclosed
BEAU SCHUYLER Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 14 (117th)

Health Issues HCR

Issues related to the development of therapies for rare diseases. Issues regarding drug pricing. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.

LobbyistCovered position, as disclosed
ANDREW ROSENBERG —
BEAU SCHUYLER Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.